Iguana Healthcare Management as of March 31, 2018
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 62 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr option | 8.7 | $13M | 50k | 263.16 | |
| Esperion Therapeutics (ESPR) | 4.8 | $7.2M | 100k | 72.33 | |
| Immunomedics | 3.8 | $5.8M | 400k | 14.61 | |
| Global Blood Therapeutics In | 3.6 | $5.6M | 115k | 48.30 | |
| Humana (HUM) | 3.5 | $5.4M | 20k | 268.85 | |
| Biogen Idec (BIIB) | 3.1 | $4.8M | 18k | 273.83 | |
| Merck & Co (MRK) | 2.9 | $4.4M | 80k | 54.48 | |
| Arena Pharmaceuticals | 2.6 | $4.0M | 100k | 39.50 | |
| Shire | 2.5 | $3.7M | 25k | 149.40 | |
| Clovis Oncology | 2.4 | $3.7M | 70k | 52.80 | |
| Esperion Therapeutics Inc Ne | 2.4 | $3.6M | 50k | 72.34 | |
| Anaptysbio Inc Common (ANAB) | 2.2 | $3.4M | 33k | 104.09 | |
| CIGNA Corporation | 2.2 | $3.4M | 20k | 167.75 | |
| Mylan Nv | 2.2 | $3.3M | 80k | 41.18 | |
| Centene Corporation (CNC) | 2.1 | $3.2M | 30k | 106.87 | |
| Bristol Myers Squibb (BMY) | 2.1 | $3.2M | 50k | 63.26 | |
| Alexion Pharmaceuticals | 2.0 | $3.1M | 28k | 111.45 | |
| Ultragenyx Pharmaceutical (RARE) | 2.0 | $3.1M | 60k | 50.98 | |
| Abbott Laboratories (ABT) | 2.0 | $3.0M | 50k | 59.92 | |
| Laboratory Corp. of America Holdings | 1.9 | $2.8M | 18k | 161.77 | |
| Adma Biologics (ADMA) | 1.8 | $2.8M | 600k | 4.60 | |
| Dex (DXCM) | 1.7 | $2.6M | 35k | 74.17 | |
| Catalyst Biosciences | 1.7 | $2.6M | 100k | 25.80 | |
| Tesaro | 1.7 | $2.6M | 45k | 57.13 | |
| Zosano Pharma Corp | 1.7 | $2.5M | 500k | 5.04 | |
| Sangamo Biosciences (SGMO) | 1.6 | $2.4M | 125k | 19.00 | |
| GlaxoSmithKline | 1.5 | $2.3M | 60k | 39.07 | |
| Rocket Pharmaceuticals (RCKT) | 1.5 | $2.3M | 125k | 18.75 | |
| Medicines Company | 1.5 | $2.3M | 70k | 32.94 | |
| Armo Biosciences Ord | 1.5 | $2.2M | 60k | 37.42 | |
| Spdr S&p Oil & Gas Exp & Pr put | 1.4 | $2.2M | 25k | 87.72 | |
| Sierra Oncology | 1.4 | $2.1M | 1.0M | 2.07 | |
| Diplomat Pharmacy | 1.3 | $2.0M | 100k | 20.15 | |
| Myokardia | 1.3 | $2.0M | 40k | 48.80 | |
| Cytomx Therapeutics (CTMX) | 1.2 | $1.8M | 65k | 28.45 | |
| Mirati Therapeutics | 1.1 | $1.7M | 55k | 30.71 | |
| Iovance Biotherapeutics (IOVA) | 1.1 | $1.7M | 100k | 16.90 | |
| Karyopharm Therapeutics | 1.1 | $1.7M | 125k | 13.42 | |
| Viking Therapeutics (VKTX) | 1.1 | $1.6M | 375k | 4.37 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.9 | $1.4M | 200k | 7.21 | |
| Merus N V (MRUS) | 0.9 | $1.4M | 75k | 18.53 | |
| Voyager Therapeutics (VYGR) | 0.9 | $1.3M | 70k | 18.79 | |
| Achaogen | 0.8 | $1.3M | 100k | 12.95 | |
| Corium Intl | 0.8 | $1.3M | 110k | 11.47 | |
| Incyte Corporation (INCY) | 0.8 | $1.2M | 15k | 83.33 | |
| Catalent | 0.8 | $1.2M | 30k | 41.07 | |
| Cerner Corporation | 0.8 | $1.2M | 20k | 58.00 | |
| Adverum Biotechnologies | 0.8 | $1.2M | 200k | 5.80 | |
| Xencor (XNCR) | 0.7 | $1.0M | 35k | 29.97 | |
| Kura Oncology (KURA) | 0.6 | $938k | 50k | 18.76 | |
| Seattle Genetics | 0.6 | $916k | 18k | 52.34 | |
| Spectrum Pharmaceuticals | 0.5 | $805k | 50k | 16.10 | |
| Dermira | 0.5 | $799k | 100k | 7.99 | |
| Assembly Biosciences | 0.5 | $737k | 15k | 49.13 | |
| Adamas Pharmaceuticals | 0.5 | $717k | 30k | 23.90 | |
| Exelixis (EXEL) | 0.4 | $665k | 30k | 22.17 | |
| Affimed Therapeutics B V | 0.4 | $555k | 300k | 1.85 | |
| Scynexis | 0.3 | $536k | 400k | 1.34 | |
| Oncomed Pharmaceuticals | 0.3 | $477k | 150k | 3.18 | |
| K2m Group Holdings | 0.3 | $474k | 25k | 18.96 | |
| Marinus Pharmaceuticals | 0.2 | $382k | 100k | 3.82 | |
| Solid Biosciences | 0.2 | $375k | 50k | 7.50 |
